South African Vaccine Producers Return To Antivenom Production
Johannesburg – The National Health Laboratory Service (NHLS), through its South African Vaccine Producers (SAVP) subsidiary, announces the successful resumption of antivenom production at its newly renovated manufacturing facility. The NHLS resumed production two weeks [...]
NHLS implements measures to address anatomical pathology challenges
Johannesburg — The National Health Laboratory Service (NHLS) acknowledges the concerns raised regarding delays in Anatomical Pathology services and wishes to provide clarity on the situation as well as the steps being taken to address [...]
NHLS Intensifies Push to Halve Toxicology Backlog by 2025/26
NHLS Intensifies Push to Halve Toxicology Backlog by 2025/26 The National Health Laboratory Service (NHLS) is implementing a targeted strategic initiative aimed at achieving a 50% reduction in toxicology case backlog by the conclusion of [...]
NHLS Monitoring Impact of U.S. Funding Freeze on HIV Testing and Research
Johannesburg, Friday, 31 January 2025 The National Health Laboratory Service (NHLS) expresses concern about the recent decision by the United States to suspend funding for HIV/AIDS initiatives. In response to the recent funding freeze, the [...]
DELAYS IN SNAKEBITE ANTIVENOM PRODUCTION
DELAYS IN SNAKEBITE ANTIVENOM PRODUCTION JOHANNESBURG: The South African Vaccine Producers (SAVP), a part of the National Health Laboratory Service, is facing delays in producing snakebite antivenom due to facility upgrades, which have led to [...]